Directions to overcome therapy resistance in cancer

Show simple item record

dc.contributor.author Nussinov, Ruth
dc.contributor.author Weichhart, Thomas
dc.contributor.author Dlamini, Zodwa
dc.contributor.author Gibbons, Don L.
dc.contributor.author Van Seuningen, Isabelle
dc.contributor.author Konen, Jessica
dc.contributor.author Ju, Huai-Qiang
dc.date.accessioned 2024-12-11T12:46:02Z
dc.date.issued 2024-06
dc.description.abstract Novel modalities for treatment of cancer have emerged because of advances in technology that have enabled expansion of our understanding of how cells transform to become cancerous and the role of the tumor microenvironment (TME). However, resistance to therapy poses a major problem for the successful treatment of cancer. Ongoing collaborative efforts of clinicians and researchers from different parts of the world have also led to an emerging understanding of how cancer cells evolve to resist treatment. Jerry Madukwe, the Editor-in-Chief of Trends in Pharmacological Sciences asked experts in the field to reflect on the global challenges in the cancer field and provide their views on what they see as the most pressing questions and research directions to overcome therapy resistance in cancer. en_US
dc.description.department Medical Oncology en_US
dc.description.embargo 2025-06-06
dc.description.librarian hj2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.uri https://www.sciencedirect.com/journal/trends-in-pharmacological-sciences en_US
dc.identifier.citation Nussinov, R., Weichhart, T., Dlamini, Z. et al. 2024, 'Directions to overcome therapy resistance in cancer', Trends in Pharmacological Sciences, vol. 45 no. 6, pp. 467-471, doi : 10.1016/j.tips.2024.05.001. en_US
dc.identifier.issn 0165-6147 (print)
dc.identifier.issn 1873-3735 (online)
dc.identifier.other 10.1016/j.tips.2024.05.001
dc.identifier.uri http://hdl.handle.net/2263/99889
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.rights © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Notice : this is the author’s version of a work that was accepted for publication in Trends in Pharmacological Sciences. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Trends in Pharmacological Sciences, vol. 45 no. 6, pp. 467-471, doi : 10.1016/j.tips.2024.05.001. en_US
dc.subject Cancer treatment en_US
dc.subject Tumor microenvironment (TME) en_US
dc.subject Therapy resistance en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title Directions to overcome therapy resistance in cancer en_US
dc.type Postprint Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record